Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.12.7.2 (
hydrogenase
)
3,522
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The particulate
hydrogenase
of Vibrio succinogenes is solubilized during treatment of cell envelopes at pH 11.0. Alkali-solubilized enzyme requires sulfhydryl compounds for activity. At neutral pH, soluble enzyme is reincorporated into alkalitreated cell envelopes and no longer requires an additional activator. In the present study, cell envelopes prepared by lysing cells with ethylenediaminetetraacetic acid plus lysozyme (EDTA-lysozyme) were used to determine the chemical composition of cell envelopes and derived pH 11.0 soluble and insoluble fractions and to investigate some properties of the binding and activation of alkali-solubilized
hydrogenase
. Lysis with EDTA-lysozyme resulted in the formation of spheroplast ghosts. The derived cell envelopes contained 61% protein, 3%
ash
, 23% lipid, and 1% phosphorus. The alkali-treated cell envelopes contained 50% protein, 2%
ash
, 24% lipid, and 1% phosphorus. The
ash
from cell envelopes and alkali-treated cell envelopes was rich in iron and phosphorus and also contained calcium, copper, magnesium, sodium, and zinc. Virtually all of the weight of the ashed samples was accounted for by the oxides of these metals. Since the reconstitution of particulate
hydrogenase
was achieved with pH 11.0 supernatant solution and precipitate, intact mucopeptide is not essential for
hydrogenase
binding. Release of
hydrogenase
during EDTA-lysozyme lysis was found to depend upon an apparent structural change which occurs in the membranes during extended storage at -20 C.
...
PMID:Chemical constituents and hydrogenase binding in cell envelopes of Vibrio succinogenes. 497 63